Last reviewed · How we verify

NCT04189913

[Trial of device that is not approved or cleared by the U.S. FDA]

WITHHELD Last updated 16 September 2021
What this trial tests

trial. Withheld.

Quick facts

Lead sponsor[Redacted]
StatusWITHHELD

Sponsor

[Redacted]

Who can join

Eligibility, any sex. Patients with the condition only — healthy volunteers not accepted.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.
    Mariados NF, Orio PF, Schiffman Z, Van TJ, et al · · 2023 · cited 55× · PMID 36757690 · DOI 10.1001/jamaoncol.2022.7592
  2. Symmetry, separation, and stability: Physical properties for effective dosimetric space with a stabilized hyaluronic acid spacer.
    Svatos M, Chell E, Low DA, Pigrish V, et al · · 2024 · cited 4× · PMID 38980082 · DOI 10.1002/mp.17292
  3. Perirectal spacers in radiotherapy for prostate cancer - a systematic review and meta-analysis.
    Miszczyk M, Stando R, Francolini G, Zamboglou C, et al · · 2025 · PMID 40330445 · DOI 10.5114/wo.2025.148388

Verify or expand the search:

Other [Redacted] trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04189913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing